Year archive

ENTROPY NEURODYNAMICS LIMITED — 2024 filings

All 81 regulatory filings released by ENTROPY NEURODYNAMICS LIMITED (ENP) in 2024, sourced directly from the official regulator.

81 Filings

2024 Period

2024 filings (81)

Filing	Released	Lang
Positive interim results in Phase 2a TRP-8802 IBS trial 4 pages 312.8KB Interim / Quarterly Report	2024-12-17	English
Phase 1b extension results meet study objectives 4 pages 291.7KB Capital/Financing Update	2024-12-15	English
Change of Director's Interest Notice - GJ 3 pages 7.1KB Director's Dealing	2024-12-03	English
Change of Director's Interest Notice - MD 3 pages 7.4KB Director's Dealing	2024-12-03	English
Change of Director's Interest Notice - CN 4 pages 8.7KB Director's Dealing	2024-12-03	English
Change of Director's Interest Notice - JC 3 pages 7.4KB Director's Dealing	2024-12-03	English
Notification regarding unquoted securities - TYP 11 pages 32.2KB Share Issue/Capital Change	2024-12-01	English
Completion of Phase 1b study of TRP-8803 in obese subjects 3 pages 262.4KB Regulatory Filings	2024-11-28	English
First patient dosed in Phase 1b study into obese subjects 3 pages 259.9KB Capital/Financing Update	2024-11-21	English
Phase 1b determines optimal parameters for TRP-8803 use 5 pages 431.5KB Capital/Financing Update	2024-11-18	English
Prospectus 45 pages 688.1KB Share Issue/Capital Change	2024-11-11	English
Proposed issue of securities - TYP 5 pages 19.3KB Share Issue/Capital Change	2024-11-11	English
Application for quotation of securities - TYP 8 pages 20.8KB Share Issue/Capital Change	2024-11-11	English
AGM CEO Presentation 27 pages 4.4MB Investor Presentation	2024-11-07	English
Results of Meeting 4 pages 266.5KB Declaration of Voting Results & Voting Rights Announcements	2024-11-07	English
Final Director's Interest Notice - PM 2 pages 217.6KB Director's Dealing	2024-11-07	English
Final Director's Interest Notice - CB 2 pages 4.7KB Director's Dealing	2024-11-07	English
Initial Director's Interest Notice - DT 2 pages 4.5KB Director's Dealing	2024-11-07	English
Resignation of Non-Executive Director 2 pages 233.5KB Board/Management Information	2024-11-05	English
Quarterly Activities Report and Appendix 4C 13 pages 664.6KB Interim / Quarterly Report	2024-10-30	English
$6m funding to fast track TRP-8803 clinical trial strategy 4 pages 324.4KB Capital/Financing Update	2024-10-29	English
Proposed issue of securities - TYP 5 pages 18.8KB Capital/Financing Update	2024-10-29	English
Proposed issue of securities - TYP 6 pages 23.1KB Capital/Financing Update	2024-10-29	English
Pause in Trading 1 page 119.1KB Regulatory Filings	2024-10-27	English
Trading Halt 3 pages 647.3KB Regulatory Filings	2024-10-27	English
TRP-8803 doses deemed safe by SRC following phase 1b study 3 pages 258.1KB Regulatory Filings	2024-10-17	English
Change in Canadian status to Designated Foreign Issuer 2 pages 218.7KB Regulatory Filings	2024-10-03	English
Change of Director's Interest Notice - JC 2 pages 5.7KB Director's Dealing	2024-10-02	English
Appendix 4G and Corporate Governance Statement 36 pages 894.6KB Governance Information	2024-09-29	English
Preliminary Final Report Reporting Adjustments 3 pages 257.2KB Annual Report	2024-09-29	English
Annual Report to shareholders 65 pages 2.9MB Annual Report	2024-09-29	English
2024 AGM Notice of Meeting, Letter of Access and Proxy 47 pages 1.1MB AGM Information	2024-09-29	English
Director transition 2 pages 238.7KB Board/Management Information	2024-09-22	English
2024 Annual General Meeting 2 pages 218.3KB AGM Information	2024-09-05	English
Appointment of Chief Financial Officer 2 pages 237.4KB Board/Management Information	2024-09-01	English
Appendix 4E Preliminary Final Report 13 pages 179.6KB Interim / Quarterly Report	2024-08-29	English
Completion of patient dosing in maiden TRP-8803 trial 3 pages 293.3KB Capital/Financing Update	2024-08-25	English
Positive Phase 2a fibromyalgia results across all patients 5 pages 794.8KB Regulatory Filings	2024-08-11	English
Trading Halt 4 pages 642.7KB Regulatory Filings	2024-08-06	English
Quarterly Activities Report and Appendix 4C 11 pages 586.2KB Interim / Quarterly Report	2024-07-30	English
Appointment of Professor Phillipa Hay to TYPs SAB 3 pages 249.6KB Board/Management Information	2024-07-29	English
TechKnow Invest Roadshow presentation and livestream links 30 pages 5.0MB Investor Presentation	2024-07-29	English
Psychiatry professor David Castle appointed to TYPs SAB 3 pages 288.5KB Board/Management Information	2024-07-28	English
First patient dosed in Phase 2a IBS trial at Mass General 3 pages 276.3KB Regulatory Filings	2024-07-23	English
Notification of cessation of securities - TYP 5 pages 16.4KB Regulatory Filings	2024-07-21	English
Phase 2a Fibromyalgia clinical study completed at U-M 3 pages 276.3KB Regulatory Filings	2024-07-09	English
Maiden dosing of TRP-8803 completed in global first 3 pages 252.7KB Capital/Financing Update	2024-06-30	English
Dr Robin Carhart-Harris renews role as SAB Chair 3 pages 170.7KB Board/Management Information	2024-06-25	English
Appointment product registration & reimbursement strategy 3 pages 295.1KB Regulatory Filings	2024-06-18	English
Change of Director's Interest Notice - JC 2 pages 5.8KB Director's Dealing	2024-06-16	English
Change of Director's Interest Notice - JC 2 pages 5.8KB Director's Dealing	2024-06-06	English
Details of Company Address 2 pages 219.6KB Regulatory Filings	2024-06-06	English
Change of Director's Interest Notice - JC 2 pages 5.8KB Director's Dealing	2024-06-05	English
Change of Director's Interest Notice - JC 2 pages 5.8KB Director's Dealing	2024-06-03	English
Change of Director's Interest Notice - JC 2 pages 5.9KB Director's Dealing	2024-05-30	English
Upcoming Expiry of Options 2 pages 225.2KB Capital/Financing Update	2024-05-30	English
Reinstatement to Quotation 1 page 423.1KB Regulatory Filings	2024-05-28	English
Investor Presentation May 2024 Precision Psychedelic Therapy 25 pages 6.4MB Investor Presentation	2024-05-28	English
Tryptamine Therapeutics Limited commences trading on the ASX 3 pages 289.4KB Capital/Financing Update	2024-05-28	English
Anticipated Reinstatement to Official Quotation 3 pages 484.2KB Capital/Financing Update	2024-05-27	English
Appendix 1A 1 page 63.7KB Regulatory Filings	2024-05-27	English
Information Form and Checklist 18 pages 188.7KB Regulatory Filings	2024-05-27	English
Replacement Prospectus 225 pages 4.4MB Capital/Financing Update	2024-05-27	English
Employee Securities Incentive Plan 52 pages 752.6KB Regulatory Filings	2024-05-27	English
Corporate Governance Statement 20 pages 255.5KB Governance Information	2024-05-27	English
Securities Trading Policy 10 pages 244.9KB Governance Information	2024-05-27	English
Distribution Schedule 1 page 65.6KB Major Shareholding Notification	2024-05-27	English
Top 20 Holders 3 pages 101.3KB Major Shareholding Notification	2024-05-27	English
Constitution 57 pages 3.0MB Regulatory Filings	2024-05-27	English
Financial Statements Tryp Therapeutics ending 31 Aug 2022 34 pages 2.0MB Regulatory Filings	2024-05-27	English
Financial Statements Tryp Therapeutics ending 31 Aug 2023 33 pages 1.9MB Regulatory Filings	2024-05-27	English
Half Year Accounts Tryp Therapeutics ending 29 Feb 2024 19 pages 568.3KB Interim / Quarterly Report	2024-05-27	English
Half Year Acc Discussion Tryp Therapeutics end 29 Feb 2024 25 pages 602.1KB Interim / Quarterly Report	2024-05-27	English
Pre-Quotation Disclosures 7 pages 286.9KB Capital/Financing Update	2024-05-27	English
Amended Anticipated Reinstatement to Official Quotation 3 pages 484.2KB Capital/Financing Update	2024-05-27	English
Securities Trading Policy 12 pages 443.1KB Governance Information	2024-05-16	English
Becoming a substantial holder - William Garner 3 pages 250.4KB Major Shareholding Notification	2024-05-06	English
Initial Director's Interest Notice - JC 2 pages 192.4KB Director's Dealing	2024-05-05	English
Initial Director's Interest Notice - CN 2 pages 163.7KB Director's Dealing	2024-05-05	English
Initial Director's Interest Notice - GJ 2 pages 163.2KB Director's Dealing	2024-05-05	English
Initial Director's Interest Notice - PM 2 pages 185.0KB Director's Dealing	2024-05-05	English

Filings by year

2026 34 filings
2024 81 filings
2023 53 filings
2022 40 filings
2021 57 filings
2020 69 filings
2019 43 filings
2018 16 filings